- Article
Relationship between Circulating PCSK9 and Markers of Subclinical Atherosclerosis—The IMPROVE Study
- Daniela Coggi,
- Beatrice Frigerio,
- Alice Bonomi,
- Massimiliano Ruscica,
- Nicola Ferri,
- Daniela Sansaro,
- Alessio Ravani,
- Palma Ferrante,
- Manuela Damigella and
- Fabrizio Veglia
- + 15 authors
(1) Background and purpose: circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) is one of the key regulators of cholesterol metabolism. Despite this, its role as a player in atherosclerosis development is still matter of debate. Here, w...

